CLOROX CO /DE/ — Form 8-K
Filed October 29, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 62/100
What the filing says
The Clorox Company announced that its Board has appointed Fabian Garcia as CEO, effective January 5, 2027, succeeding Linda Rendle who steps down for health reasons. Garcia, currently president of Unilever Personal Care with 40+ years of consumer products experience (prior roles: CEO of Revlon, COO at Colgate-Palmolive, executive at Procter & Gamble), will join the Board. Matthew Shattock will become independent chair; Rendle will serve in advisory capacity through April 2, 2027.
Why this rating
CEO transition is significant (material governance event at $19.9B company) but planned and orderly with external candidate of strong pedigree. No financial/operational disruption disclosed. Moderate positive signal offset by uncertainty inherent in leadership change.
See more from October 29, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.